Mr. Christopher Hopton reports

SIRONA BIOCHEM APPOINTS CASPER BYCH TO ITS BOARD OF DIRECTORS

Sirona Biochem Corp. has appointed Casper Bych to its board of directors.

Mr. Bych has more than 20 years experience in management, and in the legal and financial industry in Europe, South America and North America. Mr. Bych is the president and chief executive officer of Mountainview Capital Corp., a Vancouver-based corporate finance boutique that raises funds for public companies, private cash flow companies and private companies in the process of going public. Mountainview Capital has acted for companies in the resource sector, energy and medical device sectors in North America and South America. Mountainview Capital also provides financial advisory services in connection with project financings, and acts as management consultant for companies in the process of going public or undergoing merger and acquisition transactions.

Prior to founding Mountainview Capital, Mr. Bych was a securities lawyer in Vancouver. His practice was primarily focused on the health care, resource and technology sector, where he took companies public and acted for publicly traded companies. Mr. Bych holds law degrees from University of Copenhagen (Cand Jur) and McGill University.

The company also announces that Nigel Terrett has resigned as a director. The company thanks Mr. Terrett for his work over the past few years.

The company also announces that it has granted incentive stock options under its stock option plan to directors, officers and employees of the company for the purchase of 4.2 million common shares of the company at a price of 16 cents per share. Of the options, 3.6 million are for a 10-year period, while 600,000 are for a two-year period.

We seek Safe Harbor.